Director, Omnichannel Strategy

How will your role help us transform hope into reality?

Are you ready to lead the charge in transforming how we engage with our customers? Blueprint Medicines is seeking an innovative Director of Omnichannel Strategy to join our marketing team during an exciting period of tremendous growth.  As we move into the second phase of our launch for Systemic Mastocytosis (SM) and AYVAKIT, this role is critical in shifting to a customer-centric model in targeting, moving beyond a platform-focused approach.  You will be instrumental in building and executing our omnichannel strategy, ensuring that AYVAKIT continues to grow as a blockbuster therapy and revolutionize the landscape of SM.  You will have the opportunity to shape and define the omnichannel marketing landscape at Blueprint Medicines, setting new standards for customer engagement and experience.

What will you do?

Set and Build Omnichannel Strategy:

• Develop and implement a comprehensive omnichannel strategy that integrates personal and non-personal touchpoints across the customer journey.
• Lead the orchestration and alignment of omnichannel touchpoints, ensuring a seamless and cohesive customer experience.

Cross-Functional Collaboration:

• Work closely with cross-functional teams, including compliance, legal, and regulatory, to build and execute the omnichannel capability.
• Act as the strategic connector between Brand Marketing, Commercial Operations, and other stakeholders to ensure seamless communication, collaboration, and execution of omnichannel strategies.

Customer Experience Optimization:

• Develop specific customer experience activation and channel strategies across digital (web & media), peer-to-peer programming, events, and field interactions.
• Ensure the customer experience is optimized for key stakeholders, including Patients and HCPs, by leading engagement content mapping for customer segments.

Data-Driven Decision Making:

• Collaborate with Digital Operations to define KPIs and analytics, establish testing plans, and drive continuous improvement.
• Analyze and interpret data to provide actionable insights and recommendations for optimizing omnichannel strategies.

Content Development and Consistency:

• Develop content mapping and work with HCP and Patient marketing teams to ensure the right materials and messaging are created.
• Ensure content consistency and alignment with brand objectives and customer needs across all channels.

Training and Support:

• Provide training and support to internal teams on omnichannel strategies and tools.
• Stay current with industry trends and best practices in omnichannel marketing and customer experience.

Budget and Resource Management:

• Manage budgets and resources effectively to maximize ROI on omnichannel initiatives.

What minimum qualifications do we require?

• Bachelor’s degree in Marketing, Communications, Business, or a related field. Advanced degree preferred
• 8+ years of experience in marketing, with a focus on omnichannel strategy and execution
• Experience with biopharmaceuticals digital marketing, media planning, and customer experience optimization
• Experience working with chronic and/or rare diseases

What additional qualifications will make you a stronger candidate?

• Strong analytical skills with the ability to interpret data and provide actionable insights.
• Strong project management skills with the ability to manage multiple initiatives simultaneously.
• Excellent communication and interpersonal skills.
• Ability to work with cross-functional teams in the development and delivery of brand strategic imperatives.
• Strategic thinker with a passion for customer-centric marketing.
• Strong organizational skills and attention to detail.
• Ability to adapt to a fast-paced and dynamic work environment.
• Motivated by patient focus, urgency and personal commitment to high performance, results and compliance. Possesses high integrity and exceptional work ethic
• Commitment to Blueprint Medicines’ Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster a culture of equity, diversity and inclusion.  A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law.  We are also an E-Verify Employer.  We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to [email protected]. 

For more information, please see our EEO-AA Policy Statement, the EEO Know Your Rights Poster, as well as our Pay Transparency Statement. 

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.

#LI-Hybrid